Flemish population-based cancer screening programs: impact of COVID-19 related shutdown on short-term key performance indicators
暂无分享,去创建一个
[1] S. Peacock,et al. Cervical screening during the COVID-19 pandemic: optimising recovery strategies , 2021, The Lancet Public Health.
[2] E. Heijnsdijk,et al. Effects of cancer screening restart strategies after COVID-19 disruption , 2021, British Journal of Cancer.
[3] M. Poljak,et al. Impact of the COVID-19 pandemic on human papillomavirus-based testing services to support cervical cancer screening. , 2021, Acta dermatovenerologica Alpina, Pannonica, et Adriatica.
[4] A. Gambini,et al. Two-month stop in mammographic screening significantly impacts on breast cancer stage at diagnosis and upfront treatment in the COVID era , 2021, ESMO Open.
[5] P. Sasieni,et al. Recovery strategies following COVID-19 disruption to cervical cancer screening and their impact on excess diagnoses , 2021, British Journal of Cancer.
[6] I. Lansdorp-Vogelaar,et al. Impact of the COVID-19 pandemic on faecal immunochemical test-based colorectal cancer screening programmes in Australia, Canada, and the Netherlands: a comparative modelling study , 2021, The Lancet Gastroenterology & Hepatology.
[7] F. Bazzoli,et al. Impact of SARS-CoV-2 Pandemic on Colorectal Cancer Screening Delay: Effect on Stage Shift and Increased Mortality , 2020, Clinical Gastroenterology and Hepatology.
[8] M. V. Van Bockstal,et al. The Impact of the COVID-19 Pandemic and the Associated Belgian Governmental Measures on Cancer Screening, Surgical Pathology and Cytopathology , 2020, Pathobiology.
[9] G. Ferrara,et al. Cancer diagnostic rates during the 2020 ‘lockdown’, due to COVID-19 pandemic, compared with the 2018–2019: an audit study from cellular pathology , 2020, Journal of Clinical Pathology.
[10] S. Achenbach,et al. Admission of patients with STEMI since the outbreak of the COVID-19 pandemic: a survey by the European Society of Cardiology , 2020, European heart journal. Quality of care & clinical outcomes.
[11] C. Hassan,et al. COVID-19 and endoscopy: implications for healthcare and digestive cancer screening. , 2020, Nature reviews. Gastroenterology & hepatology.
[12] I. Nagtegaal,et al. Fewer cancer diagnoses during the COVID-19 epidemic in the Netherlands , 2020, The Lancet Oncology.
[13] S. Hoeck,et al. Do socioeconomic factors play a role in nonadherence to follow-up colonoscopy after a positive faecal immunochemical test in the Flemish colorectal cancer screening programme? , 2019, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.
[14] E. van Limbergen,et al. Flemish breast cancer screening programme: 15 years of key performance indicators (2002–2016) , 2019, BMC Cancer.
[15] Christopher D. Jensen,et al. Association Between Time to Colonoscopy After a Positive Fecal Test Result and Risk of Colorectal Cancer and Cancer Stage at Diagnosis , 2017, JAMA.